Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 10:00 PM
Ignite Modification Date: 2025-12-24 @ 10:00 PM
NCT ID: NCT04645732
Eligibility Criteria: Inclusion Criteria: * At least two of the following conditions: OA (knee or hip), COPD, heart condition (HF or CHD), hypertension, T2DM, depression (having other comorbidities does not exclude a patient) * Adults aged 18 years or above * Able to walk 3 meters without any assistance * A score of 3 or above on the Bayliss' Disease Burden: Morbidity Assessment by Self- Report scale for at least one of the conditions listed above and a score of 2 or above for at least one of the other listed conditions * Willingness and ability to participate in a 12-week supervised exercise therapy and self- management support program twice a week Exclusion Criteria: * Participation in supervised systematic exercise for one of their diseases within the last 3 months * Patients with an unstable health condition or at risk of serious adverse events as evaluated by a medical specialist * Patients categorized as Class IV on the New York Heart Association (NYHA) Functional Classification scale * Terminal patients and patients with life expectancy of less than 12 months * Patients with psychosis disorders, post-traumatic stress disorder, Obsessive Compulsive Disorder, attention deficit hyperactivity disorder, autism, anorexia nervosa/bulimia nervosa and patients with dependency disorders * Other reasons (unable to understand Danish, mentally unable to participate, etc.)
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Study: NCT04645732
Study Brief:
Protocol Section: NCT04645732